Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Esperion Therapeutics, Inc. | 713,602 | reported | 17 Mar 2026 | tx 20+1,447,900−34,855 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Mar 2026 | SALE | Esperion Therapeutics, Inc. | 6,424 | 2.71 USD | |
| 13 Mar 2026 | GRANT_AWARD | Esperion Therapeutics, Inc. | 247,430 | 0.00 USD | |
| 13 Mar 2026 | GRANT_AWARD | Esperion Therapeutics, Inc. | 221,270 | 0.00 USD | deriv |
| 17 Dec 2025 | SALE | Esperion Therapeutics, Inc. | 7,337 | 3.67 USD | |
| 17 Sept 2025 | SALE | Esperion Therapeutics, Inc. | 7,046 | 2.81 USD | |
| 17 Jul 2025 | SALE | Esperion Therapeutics, Inc. | 11 | 1.12 USD | |
| 17 Jun 2025 | SALE | Esperion Therapeutics, Inc. | 7,229 | 1.15 USD | |
| 17 Apr 2025 | SALE | Esperion Therapeutics, Inc. | 8 | 0.96 USD | anomaly |
| 18 Mar 2025 | SALE | Esperion Therapeutics, Inc. | 3,535 | 1.48 USD | |
| 14 Mar 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 238,000 | 0.00 USD | |
| 14 Mar 2025 | GRANT_AWARD | Esperion Therapeutics, Inc. | 213,000 | 0.00 USD | deriv |
| 19 Feb 2025 | SALE | Esperion Therapeutics, Inc. | 11 | 1.86 USD | |
| 17 Jan 2025 | SALE | Esperion Therapeutics, Inc. | 9 | 2.27 USD | |
| 17 Dec 2024 | SALE | Esperion Therapeutics, Inc. | 3,245 | 2.42 USD | |
| 14 Mar 2024 | GRANT_AWARD | Esperion Therapeutics, Inc. | 170,000 | 0.00 USD | |
| 14 Mar 2024 | GRANT_AWARD | Esperion Therapeutics, Inc. | 200,000 | 0.00 USD | deriv |
| 14 Mar 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 9,200 | 0.00 USD | |
| 14 Mar 2023 | GRANT_AWARD | Esperion Therapeutics, Inc. | 39,000 | 0.00 USD | deriv |
| 09 Dec 2022 | GRANT_AWARD | Esperion Therapeutics, Inc. | 44,000 | 0.00 USD | |
| 09 Dec 2022 | GRANT_AWARD | Esperion Therapeutics, Inc. | 66,000 | 0.00 USD | deriv |